Tag Archives: Venture Capital

Venture Capital increases in 2011, but…

The National Venture Capital Association (NVCA) has released their 4Q 2011 numbers for biotech venture financing in the US. The report echoes the global numbers already out from BioCentury and BioWorld – a boost in investment for 2011. The take away, however, is not the total amount, but 1) the drop in the total number of biotech deals, and 2) the drop in start-up, early-stage deals from 2010. The total number of deals near 447 was down Read More >

Inside BIO Industry Analysis  |  1 Comment  |  Email This Post
Tags: , , , , , , , , , ,

Multiple Assets Diversify the Deal

Partnering Meeting

With a recent surge in pharma companies collaborating earlier on with small biotech companies, discovery stage partnering deals are becoming increasingly popular.  Striking a discovery stage deal can be extremely beneficial for both parties in today’s environment – pharma gets to fill its ever elusive R&D pipeline as patent expirations loom, and the small biotech struggling to raise money to stay alive gets the capital infusion necessary to stay in play. Panelists in the “Broad Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Medical Innovation at Risk

Scientists

The National Venture Capital Association’s MedIC Coalition recently released a report showing U.S. venture capitalists are decreasing their investments in biopharmaceutical and medical device companies, reducing their concentration in prevalent disease areas and shifting investments towards Europe and Asia. The report, Vital Signs: The Threat to Investment in U.S. Medical Innovation and the Imperative of FDA Reform, strongly indicates that America’s medical innovation economy is in grave danger of losing its primary source of funding, Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Policies that Benefit Start-Ups Grow the Bio-Economy

lab

The United States remains the land of entrepreneurialism despite our lingering economic troubles. To maintain our nation’s global leadership and drive job growth, we must continue to create policies that encourage and reward innovation in growth industries — including biotechnology. Jeffrey Bussgang, a general partner at the venture capital firm Flybridge Capital Partners contributed an interesting piece to Fortune/CNN Money in which he points out that start-up companies – not small businesses – are the Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

Five things you need to know about the state of the industry

Höhere Erträge bei Trockenheit / Improving crop yields under dry conditions

What is the state of the biotechnology industry? To find out where the it stands and what strategies you need to survive, read Ernst & Young’s 25th annual industry report, Beyond borders: global biotechnology report 2011, that was released during a super session at the 2011 BIO International Convention. What were the industry’s profits last year? What kind of companies received funding? How should you engage the regulators? What new competencies do you need to Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,